Stock Groups

U.S. FDA advisers vote in favor of Pfizer/BioNTech COVID-19 vaccine in young kids -Breaking

by Mike Robinson

[ad_1]

2/2
© Reuters. FILEPHOTO: This illustration photo, taken on March 19, 2021 shows a vial labeled with Pfizer BioNTech’s coronavirus disease vaccine (COVID-19). REUTERS/Dado Ruvic

2/2

(Reuters) – The U.S. Food and Drug Administration’s panel of advisors outsiders voted on Tuesday in favor of the recommendation. Pfizer Inc (NYSE:), and BioNTechSE (NASDAQ:) The COVID-19 vaccine is for children five through eleven years old.

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



[ad_2]